Biopharmacopae Design International Raises $2M from Avrio Ventures

Biopharmacopae Design International Inc., a Quebec City, Quebec, Canada-based company that specializes in the discovery and development of innovative, science-based, plant-derived ingredients and products for the nutraceutical and cosmeceutical industries, has raised $2m in its financing round from Avrio Ventures.
The company intends to use the funds to further advance the commercialization of its new cough and cold natural health product, RIDOVIR™ Cold, and other discoveries in the Canadian and International markets.
Led by President and CEO Dr. Johane Guay, Ph.D., Biopharmacopae’s Biopharmacopae recently launched RIDOVIR™ Cold in several Canadian pharmacies and is expanding its presence by establishing additional commercial agreements with large retail stores. 
The company also joined forces with well-known pharmacist and health expert Jean-Yves Dionne. 

Join the discussion